Nivolumab and AVD in Early-stage Unfavorable Classical Hodgkin Lymphoma
Clinical trial NCT03004833 · COMPLETED
Trial details
- NCT number
- NCT03004833
- Sponsor
- University of Cologne
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-21
- Primary completion
- 2022-08-22
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.